Also known as: Acetyl Octapeptide-3

Extended SNARE complex inhibitor — argireline with two additional C-terminal residues. Greater in vitro binding affinity than argireline but higher molecular weight (1,075 Da) and weaker published evidence. Clinical data in manufacturer documentation only — not published as standalone peer-reviewed article.

📖 Read the full Snap-8 research overview →

Evidence Tier: Tier 4 — Preclinical Only · Peptidings Verdict: Eyes Open